A UK tribunal has allowed a massive lawsuit accusing Valve of anti-competitive practices to proceed, drawing vocal support from Epic Games CEO Tim Sweeney, who calls Steam the last major platform clinging to restrictive payment rules.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
Facing a new U.S. threat of tariffs on nations supplying oil to Cuba, Mexican President Claudia Sheinbaum pledges to pursue diplomatic channels and seek alternatives to avert a potential humanitarian crisis on the island, while safeguarding Mexico's own economic interests.
In a landmark shift, Venezuela's parliament has passed sweeping reforms to its hydrocarbons law, aiming to lure private capital into its crippled oil industry. The move, backed by a new U.S. license, signals a potential turning point for the nation's economy.
National Fuel Gas (NFG) reported robust first-quarter earnings, driven by a 29% surge in upstream EBITDA. Executives highlighted progress on pipeline expansions, strategic hedging against volatile gas prices, and the planned acquisition of CenterPoint's Ohio utility, while reaffirming full-year guidance.
Malaysia's state energy giant Petronas unveils a sweeping three-year plan to sustain domestic oil and gas output, expand its global LNG footprint, and position itself as a regional leader in carbon capture, navigating the complex transition toward a lower-carbon future.
In a landmark move, Venezuela's parliament has passed reforms to its hydrocarbons law, easing state control and aiming to lure back foreign capital to its struggling oil industry, coinciding with a partial easing of U.S. sanctions.
Once the engine of Venezuela's wealth, the communities around Lake Maracaibo now stand as decaying monuments to the nation's oil collapse. As a controversial U.S. plan promises a $100 billion investment, residents of the ghostly 'oil camps' are caught between desperate hope and deep-seated skepticism.
U.S. corn futures edged lower at Monday's midday, pressured by a stronger dollar, falling crude oil, and a weekly export inspections report that fell short of last year's pace. The market also digested trade developments with India and positioning data from speculators.
A landmark all-stock merger between Devon Energy and Coterra Energy will create a $58 billion powerhouse, positioning it as a top-tier producer in the prolific Permian Basin amid a wave of industry consolidation.
Asian markets opened cautiously Monday as a historic metals sell-off reverberated across asset classes. Bitcoin slipped toward $75,000, while regional equities mostly fell. Investors brace for a critical week packed with corporate earnings, central bank decisions, and key economic data.
Global markets opened the week under pressure, with Asian shares and U.S. futures declining amid renewed concerns over an AI sector bubble and falling commodity prices. South Korea's Kospi led losses with a sharp 4.6% drop.
Corn futures extended losses on Friday, pressured by a strengthening U.S. dollar and weaker crude oil prices. Despite robust export sales data running ahead of historical pace, front-month contracts fell 5 to 5.5 cents, pushing the national average cash price lower.
Despite political instability, Libya's low production costs and proximity to key markets are drawing major investment, while Venezuela's vast reserves remain hamstrung by economic and geopolitical hurdles.
Faced with mounting debt, Houston's Nine Energy Service has filed for a prepackaged Chapter 11 bankruptcy. The company, which will continue operations, has secured new financing and plans a major financial restructuring agreed upon with key lenders.
Pfizer has secured global rights to Novavax's Matrix-M adjuvant technology, aiming to develop new vaccines for infectious diseases as it seeks to diversify its portfolio beyond pandemic-related sales.
Once a high-flying AI discovery platform, AbCellera Biologics is navigating a critical transition to a clinical-stage biotech. With a fortified balance sheet and key Phase 1 readouts on the horizon, some investors see a compelling, albeit risky, turnaround story taking shape.
Simon Property Group reported robust fourth-quarter results, driven by record funds from operations and resilient leasing demand. The retail REIT giant is steering a multi-billion dollar redevelopment strategy while returning significant capital to shareholders, even as it navigates a cautious outlook for 2026.
Despite a challenging year for its stock price, a deep dive into Hess Midstream's financials suggests the midstream operator may be significantly undervalued. Our analysis examines the cash flow story behind the recent share price weakness and what it means for investors.
The medical device developer Beta Bionics has received a warning letter from the U.S. Food and Drug Administration, a regulatory action stemming from a facility inspection last summer. The company maintains the letter will not disrupt its operations, manufacturing, or the planned launch of its new insulin patch pump.
